Medochemie Continues Collaboration with OPAP Limassol 3on3 for 5th Consecutive Year as a Gold Sponsor

OPAP Limassol 3on3 is delighted to announce that Medochemie will continue its role as a Gold Sponsor of the event for the 5th consecutive year. Medochemie has been a major supporter of the streetball match from the very start and has committed to the collaboration over the years as 3on3 grew into one of the biggest events in Limassol.

Medochemie is one of the biggest pharmaceutical developers in the world offering a full package which covers everything from development to licensing, manufacturing, marketing and distributing branded, generic and super-generic pharmaceutical products as well as its own patented brands.

Established in 1976 by Dr. Andreas Pittas in Cyprus, Medochemie stands out with a strong ethos to provide quality, affordable and sustainable drug treatments to every person around the world, creating an equal platform for medication.

“Medochemie is proud to play a major part in Limassol 3on3, an event which not only brings entertainment and enthusiasm to the city, but also brings healthy activities and sports to the forefront of Limassol” said Nikos Christides, sales manager for Cyprus. “We are also excited to see the Educational training camp repeated since last year’s success and we are looking forward to being part of the most successful streetball events in Cyprus. With the recent expansion into Paphos and Protaras, it’s great to see the growth and development of such a positive sport.”

From its base in Europe, Medochemie has expanded across the world to the Middle East, Africa, Far East and the Americas. As a global mogul, Medochemie has 21 core offices as well as agents and partners in 107 countries. In addition, the company runs thirteen manufacturing plants across the globe with 4,355 marketing authorisation licenses for 630 different pharmaceutical products classified in over 10 therapeutic categories.

The multi-award winning pharmaceutical company joins an elite list of sponsors who will be supporting 3on3 event from the 31st of May to the 9th of June 2019.

Since October of 2018 Medichemie has added a number of strings to their bow, including launching Rovasta in Jordan, partnering with Pfizer in Vietnam, receiving the  Gold Environment Keeper 2018 award at the Pancyprian Environmental Awards and Dr. Andreas Pittas, Founder and Executive Chairman of Medochemie, received the Lifetime Achievement Award at the IN ‘Business Awards 2018’. It is this type of company that puts Cyprus on the world map.

Share this postShare on Facebook
Tweet about this on Twitter